Dewi, D., Blanco, S., Adam, I., Weichenhan, D., Schott, S., Plass, C., . . . Opitz, C. (2017). Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer. OncoImmunology, 6(2), . https://doi.org/10.1080/2162402X.2016.1274477
Chicago-Zitierstil (17. Ausg.)Dewi, Dyah, et al. "Suppression of Indoleamine-2,3-dioxygenase 1 Expression by Promoter Hypermethylation in ER-positive Breast Cancer." OncoImmunology 6, no. 2 (2017). https://doi.org/10.1080/2162402X.2016.1274477.
MLA-Zitierstil (9. Ausg.)Dewi, Dyah, et al. "Suppression of Indoleamine-2,3-dioxygenase 1 Expression by Promoter Hypermethylation in ER-positive Breast Cancer." OncoImmunology, vol. 6, no. 2, 2017, https://doi.org/10.1080/2162402X.2016.1274477.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.